PetIQ, Inc. in brief
PetIQ, Inc. is an unlisted company in the Pharmaceutical industry, based in Idaho, USA. In the year to Dec 2021 it had sales of $932 M and a net loss of $15 M. It employs about 1,452 people.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About PetIQ, Inc.
Animals healthcare company with headquarters is in Idaho, USA
PetIQ, Inc. timeline
- 2017
- 🔔· approximateInitial public offering on Nasdaq
Events of PetIQ, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about PetIQ, Inc.
- Acquisitions and changes
- No longer listed: ticker PETQ is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #2,229 (Jan 2020) · #2,072 (Jan 2021) · #3,062 (Jan 2022) · #3,357 (Dec 2022) · #2,735 (Jul 2023) · #2,445 (Jan 2024)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- -1.6%
- Operating margin
- —
- Return on equity
- -5.9%
- Liabilities / assets
- 68.9%
- Revenue per employee
- $642 K
- Profit per employee
- $-10 K
Annual results
- Revenue
- $932 M
- Operating income
- —
- Net income
- $-15 M
Dec-2021 ending year
Balance sheet
- Total assets
- $819 M
- Total liabilities
- $564 M
- Total equity
- $255 M
Dec-2021 ending year
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | · | · | · | · | · | · | 55 | · | · | · | · | · | 55 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| effective | 55 people | ClosureWARN notice | Sonoma County, California | Notice list |
Source: State WARN notices and SEC 8-K item 2.05
How PetIQ, Inc. compares in Pharmaceutical
- Revenue$932 M · higher than 63% of 324
- Net margin-1.6% · higher than 27% of 313
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| PetIQ, Inc.🇺🇸 | $558 M | — | -1.6% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Employees:
- As on 2020
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at PetIQ, Inc.? Verify and update this profile — free
Show PetIQ, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.